← All Posts
CVS
CVS Health Corporation
May 15, 2026
•
Author: Phil Ratcliff
| Item |
Proposal |
Vote |
| 1 |
Election of Directors. |
|
| 1a |
Fernando Aguirre |
✓ For(99.323)
|
| 1b |
Jeffrey R. Balser, M.D., Ph.D. |
✓ For(99.323)
|
| 1c |
C. David Brown II |
✓ For(99.323)
|
| 1d |
Alecia A. DeCoudreaux |
✓ For(99.323)
|
| 1e |
Anne M. Finucane |
✓ For(99.323)
|
| 1f |
John E. Gallina |
✓ For(99.323)
|
| 1g |
J. David Joyner |
✗ Against(99.323)
|
| 1h |
J. Scott Kirby |
✓ For(99.323)
|
| 1i |
Michael F. Mahoney |
✓ For(99.323)
|
| 1j |
Leslie V. Norwalk |
✗ Against(99.323)
|
| 1k |
Larry M. Robbins |
✓ For(99.323)
|
| 1l |
Guy P. Sansone |
✓ For(99.323)
|
| 1m |
Douglas H. Shulman |
✓ For(99.323)
|
| 2 |
Ratification of the Appointment of Our Independent Registered Public Accounting Firm for 2026. |
✓ For(99.323)
|
| 3 |
Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company’s Executive Compensation. |
✓ For(99.323)
|
| 4 |
Proposal to Approve the Company’s 2026 Incentive Compensation Plan. |
✓ For(99.323)
|
| 5 |
Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. |
✗ Against(99.323)
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.
rebel Financial